Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Nitrogen containing other than solely as a nitrogen in an...
Patent
1994-12-06
1997-01-07
Cintins, Marianne M.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Nitrogen containing other than solely as a nitrogen in an...
514595, 514599, 514617, 564 26, 564 47, 564 74, 564189, 564190, 564192, 564209, A61K 3116, A61K 3117, C07C33506, C07C27506
Patent
active
055917755
ABSTRACT:
The invention relates to a compound selected from those of formula (I): ##STR1## in which R, R.sub.1, R.sub.2 and R.sub.3 are as defined herein for use in the treatment of a disorder of the melatoninergic system.
REFERENCES:
Yous et al., J. Med. Chem. 35(8), pp. 1484-1486 (1992).
CAS Abstract of published German Patent Application DE3828566, 1990.
Derwent Abstract of published German Patent Application DE3828566, 1990.
J. Med. Chem. 35, pp. 1484-1486 (1992).
Moritoki H. et al., Eur. J. Pharmacol. 35, pp. 185-198 (1976).
Morgan P. Journal of Neuroendocrinology 1, pp. 1-4 (1989).
Adam Gerard
Delagrange Philippe
Depreux Patrick
Lefoulon Fran.cedilla.ois
Lesieur Daniel
Adir et Compagnie
Cintins Marianne M.
Spivack Phyllis G.
LandOfFree
Trisubstituted naphthylalkylamides for disorders of the melatoni does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Trisubstituted naphthylalkylamides for disorders of the melatoni, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Trisubstituted naphthylalkylamides for disorders of the melatoni will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1764750